Prolonged versus standard native E. coli asparaginase therapy in childhood acute lymphoblastic leukemia and non-Hodgkin lymphoma: final results of the EORTC-CLG randomized phase III trial 58951-Reference-Cited by-同舟云学术

Prolonged versus standard native E. coli asparaginase therapy in childhood acute lymphoblastic leukemia and non-Hodgkin lymphoma: final results of the EORTC-CLG randomized phase III trial 58951

Published:2017-07-27 Issue:10 Volume:102 Page:1727-1738
ISSN:0390-6078
Container-title:Haematologica
language:en
Short-container-title:Haematologica

Author:

Mondelaers Veerle,Suciu Stefan,De Moerloose Barbara,Ferster Alina,Mazingue Françoise,Plat Geneviève,Yakouben Karima,Uyttebroeck Anne,Lutz Patrick,Costa Vitor,Sirvent Nicolas,Plouvier Emmanuel,Munzer Martine,Poirée Maryline,Minckes Odile,Millot Frédéric,Plantaz Dominique,Maes Philip,Hoyoux Claire,Cavé Hélène,Rohrlich Pierre,Bertrand Yves,Benoit Yves

Publisher

Ferrata Storti Foundation (Haematologica)

Subject

Hematology

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Refining risk prediction in pediatric acute lymphoblastic leukemia through DNA methylation profiling;Clinical Epigenetics;2024-03-28

2. The frequency of NUDT15 rs116855232 and its impact on mercaptopurine-induced toxicity in Syrian children with acute lymphoblastic leukemia;Frontiers in Oncology;2024-03-18

3. Four Additional Doses of PEG-L-Asparaginase During the Consolidation Phase in the AIEOP-BFM ALL 2009 Protocol Do Not Improve Outcome and Increase Toxicity in High-Risk ALL: Results of a Randomized Study;Journal of Clinical Oncology;2023-12-14

4. Refining risk prediction in pediatric Acute Lymphoblastic Leukemia through DNA methylation profiling;2023-12-07

5. What Is Next in Pediatric B-Cell Precursor Acute Lymphoblastic Leukemia;Lymphatics;2023-05-12